Who
Christopher J. Nardo
Senior VP, CDO
Company insider
Files Form 4 as: Senior VP, CDO, Dermata Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Aug 2021
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 13 Jan 2025filed 14 Jan 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Jan 2024filed 5 Jan 2024 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 1 Jul 2022filed 7 Jul 2022 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 17 Aug 2021filed 17 Aug 2021 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —50,000 at $0.00 | filing |
| 17 Aug 2021filed 17 Aug 2021 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code C | —2,439 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.